Sale!

TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the TRPM7 gene associated with increased risk for developing this complex neurological condition. Using Next-Generation Sequencing (NGS) technology, this comprehensive test provides crucial insights into genetic susceptibility to ALS, Parkinsonism, and dementia spectrum disorders. The test is particularly valuable for individuals with family history of neurological conditions or those experiencing early symptoms. Results help guide preventive strategies, inform treatment decisions, and provide clarity for family planning. The test is available for $500 USD and provides detailed genetic counseling support throughout the process.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility NGS Genetic DNA Test

Understanding the TRPM7 Gene and Neurological Disorders

The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility NGS Genetic DNA Test represents a breakthrough in neurological genetic testing. This comprehensive analysis examines the TRPM7 gene, which plays a critical role in neuronal function and has been linked to increased susceptibility for developing complex neurodegenerative conditions. The test utilizes advanced Next-Generation Sequencing technology to provide detailed insights into your genetic predisposition for these serious neurological disorders.

What Does This Test Measure and Detect?

This sophisticated genetic test specifically targets the TRPM7 gene, which encodes a transient receptor potential cation channel involved in magnesium homeostasis and neuronal signaling. The test detects:

  • Pathogenic variants in the TRPM7 gene associated with ALS-Parkinsonism-Dementia Complex
  • Single nucleotide polymorphisms (SNPs) that may increase disease susceptibility
  • Copy number variations affecting TRPM7 gene function
  • Rare mutations linked to early-onset neurological symptoms

Who Should Consider This Genetic Test?

Individuals with Specific Risk Factors

This test is particularly recommended for:

  • Individuals with a family history of ALS, Parkinsonism, or early-onset dementia
  • Patients experiencing unexplained neurological symptoms including muscle weakness, tremors, or cognitive changes
  • Those with a known TRPM7 gene mutation in their family
  • Individuals planning families who have concerns about inherited neurological conditions
  • Patients with atypical or complex neurological presentations

Early Warning Signs and Symptoms

Consider testing if you experience:

  • Progressive muscle weakness or atrophy
  • Involuntary muscle twitching or fasciculations
  • Tremors or movement difficulties
  • Memory problems or cognitive decline
  • Speech or swallowing difficulties
  • Balance and coordination issues

Benefits of Taking the TRPM7 Gene Test

Comprehensive Health Insights

This test provides numerous advantages for proactive health management:

  • Early Risk Assessment: Identify genetic susceptibility before symptoms develop
  • Personalized Prevention: Implement targeted lifestyle and monitoring strategies
  • Family Planning Guidance: Make informed decisions about genetic inheritance
  • Treatment Planning: Guide healthcare providers in developing appropriate care plans
  • Peace of Mind: Reduce uncertainty about neurological health risks

Understanding Your Test Results

Interpreting Genetic Findings

Your test results will be carefully explained by our genetic counseling team:

  • Positive Result: Indicates the presence of a TRPM7 gene mutation associated with increased susceptibility. This does not guarantee disease development but suggests elevated risk.
  • Negative Result: No known pathogenic variants detected, though this doesn’t eliminate all risk for neurological conditions.
  • Variant of Uncertain Significance: Some genetic changes require further research to determine clinical significance.

Next Steps After Testing

Based on your results, our specialists will recommend:

  • Regular neurological monitoring and follow-up care
  • Lifestyle modifications to support brain health
  • Family member testing recommendations if applicable
  • Referrals to appropriate specialists for ongoing management

Test Information and Pricing

Test Component Details
Test Name TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures you receive comprehensive support throughout the testing process.

Take Control of Your Neurological Health Today

Don’t wait to gain valuable insights into your genetic predisposition for neurological conditions. Our TRPM7 Gene Test provides the advanced genetic analysis you need for informed health decisions. With our discounted price of $500 USD, comprehensive genetic counseling, and nationwide availability, there’s never been a better time to prioritize your neurological health.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility NGS Genetic DNA Test and take the first step toward understanding your genetic health.